Evidence map›Paper›PMID 16230486›Full record

ArticleCirculation2005

Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome.

Marvin S Medow, Christopher T Minson, Julian M Stewart

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Circulation, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01308099 (Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome), which is not on this map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01308099 completednot on this mapstarted 2011, after this paper: background citation

Assessment of Vascular Endothelial Function in Postural Tachycardia Syndrome (POTS)

TypeobservationalSponsorVanderbilt University Medical CenterRan2011 to 2017Enrolled26ConditionsPostural Tachycardia SyndromeArmsBlood Pressure and Blood Flow
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response.American journal of physiology. Heart and circulatory physiology · 2008
    Trial
  3. Trial
  4. Article
  5. Article
  6. Cutaneous manifestations of orthostatic intolerance syndromes.International journal of women's dermatology · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Blunted cerebral blood flow velocity in response to a nitric oxide donor in postural tachycardia syndrome.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  19. Review
  20. Ascorbate improves circulation in postural tachycardia syndrome.American journal of physiology. Heart and circulatory physiology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marvin S MedowNew York Medical College, Valhalla, NY, USA.
Christopher T Minson
Julian M Stewart
New York Medical College · US

Funding

Local Vasoconstriction in Postural Tachycardia SyndromeR01HL074873 · NHLBI · NEW YORK MEDICAL COLLEGE · PI STEWART, JULIAN M · 2004 to 2013
$3.4M
Vascular Dysfunction in CFSR01HL087803 · NHLBI · NEW YORK MEDICAL COLLEGE · PI STEWART, JULIAN M · 2008 to 2011
$1.6M
Circulatory Dysfunction in Chronic Fatigue SyndromeR01HL066007 · NHLBI · NEW YORK MEDICAL COLLEGE · PI STEWART, JULIAN M · 2001 to 2004
$938k
NHLBI NIH HHS 1R01HL074873NHLBI NIH HHS 5R01HL66007NHLBI NIH HHS R01 HL066007NHLBI NIH HHS R01 HL074873NHLBI NIH HHS R01 HL087803
6 · The paper itself

Abstract

backgroundOne variant of postural tachycardia syndrome (POTS), designated low-flow POTS, is associated with decreased peripheral blood flow related to impaired local vascular regulation. METHODS AND

resultsTo investigate the hypothesis that microvascular endothelial dysfunction produces decreased peripheral blood flow in low-flow POTS, we performed experiments using laser-Doppler flowmetry (LDF) combined with iontophoresis in 15 low-flow POTS patients, 17 normal-flow POTS patients, and 13 healthy reference volunteers varying in age from 14 to 22 years. We tested whether alpha-adrenergic vasoregulation was impaired using iontophoretic delivery of tyramine, phentolamine, and bretylium followed by a norepinephrine dose response. We tested endothelial-dependent and -independent receptor-mediated vasodilation by measuring acetylcholine and sodium nitroprusside dose responses. We tested whether nitric oxide-dependent vasodilation was different in these groups by testing the local thermal hyperemic response to saline used as a reference compared with the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME). Adrenergic and receptor-dependent cutaneous vasoregulation was similar for low-flow POTS, normal-flow POTS, and reference subjects. Thermal hyperemia produced distinctly different findings: there was marked attenuation of the nitric oxide-sensitive plateau during prolonged heating, which was insensitive to L-NAME in low-flow POTS subjects. The pattern of thermal hyperemia response in low-flow POTS subjects during saline administration resembled the pattern in reference subjects during L-NAME administration and was minimally affected by L-NAME.

conclusionsThe data suggest that flow-dependent nitric oxide release is reduced in low-flow POTS. This may account for local flow regulation abnormalities.

Indexed as

AdolescentAdrenergic AgonistsAdrenergic AntagonistsAdultHumansHypotension, OrthostaticMicrocirculationNG-Nitroarginine Methyl EsterNitric OxidePostureSyndromeTachycardiaTilt-Table TestVasodilationAdrenergic AgonistsAdrenergic AntagonistsNG-Nitroarginine Methyl EsterNitric Oxide

Identifiers

PMID16230486
PMCPMC4511487
OpenAlexW2025957772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.